Why China's vaccines are gaining international momentum


BEIJING (CGTN): There has been much news of late concerning Covid-19 vaccine progress from the two big American pharmacy firms, Pzifer and Moderna. It is hardly a surprise that the mainstream media behave as if these are the only two vaccine options available in the world and give them preferential coverage.

However, equal to the progress these companies have made, a number of Chinese firms are also pacing forward with third stage clinical trials of a coronavirus vaccine.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , vaccine , covid-19 , covax , Tom Fowdy , CGTN

   

Next In Aseanplus News

Second Australian dies after suspected Laos poisoning bringing tragedy total to six
FBM KLCI rebounds after three days of losses
Nurul Izzah invited on overseas trip in her capacity as think tank chairman, says Fahmi
ICC's arrest warrants for Netanyahu, Gallant appropriate, says Anwar
Wuzhen Summit: China creates AI advisory body, with Alibaba Cloud founder as chief expert
Singaporean woman being investigated for suspected terrorism-related activities, says Internal Security
S'gor govt yet to receive update on probe into Faisal Halim's case
Indonesian parliament designates Jakarta as special region after being removed as capital city
Malaysia's top two squash player storm into S'pore Open semis
Thai court dismisses activist's suit against Israeli spyware producer over lack of evidence

Others Also Read